Loading...

Cannara Biotech Inc.

LOVE.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
$1.75
$0.00(0.00%)
Canadian Market opens in 3h 25m

Cannara Biotech Inc. (LOVE.TO) Stock Overview

Explore Cannara Biotech Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap172.9M
P/E Ratio13.89
EPS (TTM)$0.11
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

LOVE.TO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cannara Biotech Inc. (LOVE.TO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.89 and a market capitalization of 172.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-1.69%
1-Month Change
-4.37%
3-Month Change
-5.91%
6-Month Change
6.71%
Year-to-Date (YTD) Change
0.57%
1-Year Change
26.81%
3-Year Change
113.41%
5-Year Change
12.90%
All-Time (Max) Change
-42.62%

Contact Information

https://cannara.ca
514 543 4200
333 Decarie Blvd., Saint-Laurent, QC, H4N 3M9

Company Facts

452 Employees
IPO DateJan 14, 2019
CountryCA
Actively Trading

Frequently Asked Questions